Home » Topics » Regulatory

Regulatory
RSS

Once-daily Adderall XR approved by FDA for ADHD; registration trial discussed at CNS meeting

Oct. 19, 2001

First approval granted for Spiriva in The Netherlands for treatment of COPD

Oct. 19, 2001

FDA advisory committee decision on Diovan for heart failure indication

Oct. 19, 2001

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

GSK seeks European approval of Seretide for COPD

Oct. 18, 2001

Foradil now cleared for use in COPD in the U.S.

Oct. 17, 2001

Health Canada approves enhanced labeling for Copaxone

Oct. 17, 2001

ODAC meeting rescheduled for early December

Oct. 17, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...